Ubs Group Ag Moderna, Inc. Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Moderna, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,081,761 shares of MRNA stock, worth $71.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,081,761

Previous 216,100 400.58%

Holding current value

$71.1 Million

Previous $23 Million 457.86%

% of portfolio

0.03%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $6.54 Million - $10.8 Million	64,573 Added 6.35%	1,081,761 $128 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $12.3 Million - $16.6 Million	143,919 Added 16.48%	1,017,188 $108 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $8.32 Million - $12.5 Million	-119,743 Reduced 12.06%	873,269 $86.8 Million
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $24.7 Million - $32.5 Million	256,471 Added 34.82%	993,012 $103 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $21.6 Million - $29.3 Million	182,377 Added 32.91%	736,541 $89.5 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $14.2 Million - $20.6 Million	104,588 Added 23.26%	554,164 $85.1 Million
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $16.3 Million - $28.9 Million	137,479 Added 44.05%	449,576 $80.8 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $13.6 Million - $22.4 Million	-115,255 Reduced 26.97%	312,097 $36.9 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $7.28 Million - $11 Million	62,194 Added 17.03%	427,352 $61 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $43.8 Million - $81.4 Million	-346,161 Reduced 48.66%	365,158 $62.9 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $11.7 Million - $19 Million	-51,687 Reduced 6.77%	711,319 $181 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $77.4 Million - $169 Million	348,592 Added 84.12%	763,006 $294 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $6.74 Million - $12.2 Million	-51,919 Reduced 11.13%	414,414 $97.4 Million
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $14.8 Million - $25.2 Million	135,544 Added 40.98%	466,333 $61.1 Million
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $2.84 Million - $7.35 Million	43,258 Added 15.04%	330,789 $34.6 Million
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $813,687 - $1.42 Million	14,974 Added 5.49%	287,531 $20.3 Million
Q2 2020 Jul 31, 2020	BUY	$29.67 - $80.0 $4.96 Million - $13.4 Million	167,322 Added 159.0%	272,557 $17.5 Million
Q1 2020 May 01, 2020	BUY	$17.78 - $31.58 $1.68 Million - $2.99 Million	94,626 Added 891.94%	105,235 $3.15 Million
Q4 2019 Feb 14, 2020	SELL	$13.93 - $21.28 $685,982 - $1.05 Million	-49,245 Reduced 82.28%	10,609 $208,000
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $420,763 - $620,162	34,320 Added 134.41%	59,854 $952,000
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $221,241 - $457,662	16,149 Added 172.07%	25,534 $374,000
Q1 2019 May 14, 2019	BUY	$14.45 - $23.7 $103,823 - $170,284	7,185 Added 326.59%	9,385 $191,000
Q4 2018 Feb 14, 2019	BUY	$13.52 - $18.8 $29,744 - $41,360	2,200 New	2,200 $34,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account